Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
CAD developer R2 Technology Inc. this week appointed William J. Mercer as interim president and CEO, succeeding Michael Klein who resigned late last week.
DOBI Medical International Inc. this week reached agreement with the Food and Drug Administration (FDA) to conduct a multi-site clinical trial on its ComfortScan imaging system.
U.S. Electronics Inc. (USEI), of Minneapolis has received 510(k) clearance from the FDA to market its ME511L, five-megapixel, monochrome LCD, flat-panel display for use with picture archiving and communication systems (PACS) in the United States.
Misys Healthcare Systems and Texas Health Resources (THR) have inked a multimillion-dollar agreement to extend the Misys Radiology Information System (RIS) across inpatient and ambulatory settings to streamline access to medical imaging reports and diagno
Blessing Hospital in Quincy, Ill., has purchased ScImage's PICOMEnterprise PACS to integrate it with the facility's Eclipsys Corp.'s Sunrise clinical information system.
Consorta Inc. has renewed a three-year agreement with Medrad Inc. as the exclusive supplier of vascular injection systems and related disposables for CT, MR and cardiovascular (CV) imaging.
Eclipsys Corp. has formed a strategic relationship with Van Slyck & Associates Inc. (VSA), combining Eclipsys' advanced clinical software with Van Slyck's patient classification/acuity methodology.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
